Corey Clay, MD
Allergy & Immunology · Santa Fe, NMNPI 1417247727
Payments from drug & device makers
Across 553 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Regeneron Healthcare Solutions, Inc.$818
- CSL Behring$763
- Sanofi$521
- plus $3K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 144 | $3,111 |
| GSK | 92 | $1,546 |
| Takeda Pharmaceuticals U.S.A., Inc. | 86 | $1,500 |
| Regeneron Healthcare Solutions, Inc. | 32 | $818 |
| CSL Behring | 33 | $763 |
| Sanofi | 22 | $521 |
| Grifols USA, LLC | 21 | $413 |
| Novartis | 19 | $372 |
| Incyte Corporation | 14 | $264 |
| Blueprint Medicines Corporation | 9 | $221 |
| Pharming Healthcare, Inc. | 8 | $220 |
| Genentech USA, Inc. | 6 | $151 |
| Boehringer Ingelheim | 7 | $129 |
| Stryker | 1 | $125 |
| AbbVie | 7 | $124 |
| Lilly USA, LLC | 5 | $96 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $94 |
| Amgen | 4 | $92 |
| Pfizer | 6 | $86 |
| Biocryst US Sales Co., LLC | 4 | $78 |
| Ionis Pharmaceuticals, Inc. | 2 | $65 |
| Optinose US, Inc. | 3 | $55 |
| Covis Pharma GmbH | 4 | $53 |
| Cycle Pharmaceuticals Inc | 2 | $46 |
| Merck | 3 | $43 |
| Shire North American Group Inc | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 3 | $36 |
| Tersera Therapeutics LLC | 2 | $35 |
| Bio Products Laboratory USA, Inc. | 3 | $34 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| ADMA Biomanufacturing LLC | 1 | $15 |
| Alk-abello, Inc | 1 | $14 |
| Kaleo, Inc. | 1 | $11 |
How this compares
Too few allergy & immunology providers in New Mexicoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Santa Fe
- James SussmanSanta Fe$9K
- Janna TuckSanta Fe$4K
- Todd FunkhouserLas Cruces$5.1M
- Osman DokmeciAlbuquerque$164K
- Michael RuppLas Cruces$41K
- Amanda Grippen GoddardAlbuquerque$14K
- Jack GhablyAlbuquerque$14K
- Shanze WangAlbuquerque$12K
- Teresa Jenkins-MccordAlbuquerque$10K
- Steven TolberAlbuquerque$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.